215
Views
7
CrossRef citations to date
0
Altmetric
Nephrology

Low-calcium dialysate as a risk factor for decline in bone mineral density in peritoneal dialysis patients

, , , &
Pages 454-460 | Received 29 Jan 2012, Accepted 04 Jun 2012, Published online: 31 Aug 2012

References

  • Lindsay RS, Cosman F. Osteoporosis. In Harrison's Principles of internal medicine. 17th ed. New work: McGraw-Hill Book Co; 2008. 2397–408.
  • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95.
  • Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000;58:396–9.
  • Jeong JU, Lee HK, Kim YJ, Kim JS, Kang SS, Kim SB. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients. Clin Nephrol 2010;74:336–42.
  • Ersoy F, Passadakis S, Tam P, Memmos E, Katopodis P, Ozener C, Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis. J Bone Miner Metab 2006;24:79–86.
  • Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int 2008;74:721–31.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1–201.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int 2009;113:S1–130.
  • Buijsen CG, Struijk DG, Huijgen HJ, Boeschoten EW, Wilmink JM. Can low-calcium peritoneal dialysis solution safely replace the standard calcium solution in the majority of chronic peritoneal dialysis patients?. Perit Dial Int 1996;16:497–504.
  • Armstrong A, Beer J, Noonan K, Cunningham J. Reduced calcium dialysate in CAPD patients: efficacy and limitations. Nephrol Dial Transplant 1997;12:1223–8.
  • Sanchez C, Lopez-Barea F, Sanchez-Cabezudo J, Bajo A, Mate A, Martinez E, Low vs standard calcium dialysate in peritoneal dialysis: difference in treatment, biochemistry and bone histomorphometry. A randomized multicentre study. Nephrol Dial Transplant 2004;19:1587–93.
  • Haris A, Sherrard DJ, Hercz G. Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int 2006;70:931–7.
  • Haris A, Sherrard DJ, Hercz G. Response to “The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient”. Kidney Int 2007;71:594–5.
  • Reich HN, Troyanov S, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007;18:3177–83.
  • Clarkson EM, McDonald SJ, de Wardner HE. The effects of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin Sci 1966;30:425–38.
  • Martis L, Serkes KD, Nolph KD. Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using CaCO3? Perit Dial Int 1989;9:325–8.
  • Yavuz A, Ersoy FF, Passadakis PS, Tam P, Evaggelos DM, Katopodis KP, Phosphorus control in peritoneal dialysis patients. Kidney Int 2008;73:S153–8.
  • Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 2006;24:79–86.
  • Boink AB, Buckley BM, Christiansen TF, Covington AK, Maas AH, Müller-Plathe O, IFCC recommendation on sampling, transport and storage for the determination of the concentration of ionized calcium in whole blood, plasma and serum. J Automat Chem 1991;13:235–9.
  • Hutchison AJ, Freemont AJ, Boulton HF, Gokal R. Low calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphatemia whilst minimizing aluminum exposure and hypercalcemia. Nephrol Dial Transplant 1992;7:1219–25.
  • Weinreich T, Passlick-Deetjen J, Ritz E; for the Collaborators of the Peritoneal Dialysis Multicenter Study Group. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. Am J Kidney Dis 1995;25:452–60.
  • Martin KJ, Floege J, Ketteler M. Bone and mineral metabolism in chronic kidney disease. In Floege J, Johnson RJ, Feehally J. editors Comprehensive clinical nephrology. 4th ed. Philadelphia, PA: Saunders; 2010. p 969–84.
  • Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Association of kidney function, vitamin D deficiency, and circulating markers of mineral bone disorders in CKD. Am J Kidney Dis 2011;58:544–53.
  • Eastell R, Arnold A, Brandi ML, Brown EM, D’Amour P, Hanley DA, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:340–50.
  • Ambrus C, Marton A, Nemeth ZK, Mucsi I. Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol 2010;42:723–39.
  • Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999;14:1922–8.
  • Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 2006;24:79–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.